Ipsos acquires InMoment’s healthcare division in Germany

PARIS - Market research company Ipsos, currently valued at $2.17 billion, announced Monday the acquisition of InMoment’s Healthcare division in Germany, expanding its expertise in the pharmaceutical and medical technology sectors.

The acquisition adds a new competence center for Ipsos’s Healthcare Service Line in Hamburg, complementing its existing locations in Nuremberg, Munich and Frankfurt, according to a company press release.

"We are pleased to welcome the experienced InMoment German Healthcare team to Ipsos," said Ben Page, CEO of Ipsos. The move is expected to provide additional value for Ipsos’s local and global clients through expanded therapeutic area expertise and a broader methodological portfolio.

The financial terms of the acquisition were not disclosed in the announcement.

Ipsos, headquartered in France, is one of the world’s largest market research companies, operating in 90 markets with approximately 20,000 employees. The company serves about 5,000 clients globally and has been listed on the Euronext Paris since July 1, 1999.

The acquisition represents Ipsos’s strategic effort to strengthen its position in the German healthcare research market, adding specialized capabilities to its existing operations in the country.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Ipsos acquires InMoment’s healthcare division in Germany

Market research company Ipsos announced the acquisition of InMoment’s healthcare division in Germany, expanding its expertise in pharmaceutical and medical technology sectors. The acquisition adds a new competence center in Hamburg, complementing existing locations in Nuremberg, Munich, and Frankfurt. Financial terms were not disclosed, and the move is part of Ipsos’s strategy to strengthen its position in the German healthcare research market.